Immunome, Inc.

Immunome, Inc. financial statements

Immunome, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 6.94M10-K
Net income−USD 212.39M10-K
Cash and equivalentsUSD 653.48M10-Q
Total debtUSD 3.85MEODHD

Immunome, Inc. financials on 6ix · Immunome, Inc. on 6ix